Roche Diagnostics wins Leicester's ME2 Network pathology managed service
- University Hospitals of Leicester NHS Trust
- Call-off from a framework agreement, 1 bid
- 4 June 2026 to 3 June 2036
Roche Diagnostics runs a pathology managed service for University Hospitals of Leicester NHS Trust, as part of the Midlands and East 2 (ME2) Network. The network is a pathology collaboration of NHS trusts across the Midlands and East 2 region.
In the first phase, Roche Diagnostics provides biochemistry and haematology, with the analytical equipment for both. The company also manages the second phase, which covers disciplines such as microbiology, immunology and cellular pathology. For those it manages subcontractors, after scoping requirements and testing the market.
The network ran a further competition under Lot 1 of the NHS Supply Chain Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service framework. Roche Diagnostics made the only bid and won the £32m contract in June 2026. It runs to June 2036.
Contract ends June 2036
- What
- Pathology managed services and blood sciences analysers
- Supplier
- Roche Diagnostics
- Value
- £32m
- How it was bought
- Call-off from a framework agreement
- 1 bid
- Dates and next
- Jun 2026 to Jun 2036